WASHINGTON (AFP) A pink pill marketed by German drug firm Boehringer Ingelheimas a libido-booster for women has produced inconclusive results in two clinical trials, the US Food and Drug Administration (FDA) said.Originally intended as an anti-depressant, the drug flibanserin in the form of a pink pill began being tested years ago as a potential libido aid after women said it failed to fight t